We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioFocus DPI and Carna Biosciences Offer Kinase Profiling Services
News

BioFocus DPI and Carna Biosciences Offer Kinase Profiling Services

BioFocus DPI and Carna Biosciences Offer Kinase Profiling Services
News

BioFocus DPI and Carna Biosciences Offer Kinase Profiling Services

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BioFocus DPI and Carna Biosciences Offer Kinase Profiling Services"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioFocus DPI has announced that it has formed an alliance with Carna Biosciences to offer a platform for the characterization of kinase inhibitors. 

This profiling technology is designed to enable identification of hit and lead molecules for kinase drug discovery.

Carna’s kinase profiling collection contains 150 active protein kinases - representing all major branches of the human kinome. 

With a turnaround time of three weeks, the kinase profiling service offered by BioFocus DPI integrates well with medicinal chemistry timelines. 

"We are pleased to add kinase profiling to our range of drug discovery services," said Dr. Bernhard Schnurr, Senior Director of Biology at BioFocus DPI’s site in Basel. 

"In reviewing existing kinase profiling technologies, both the quantity and quality of kinases in Carna’s panel stood out above its competitors’ offerings."

"The Carna kinase profiling technology will complement BioFocus DPI’s service offering to help our customers develop safe and effective therapeutics."

Advertisement